Inventor · disambiguated record
Barton F. Haynes
Also filed as: HAYNES BARTON · HAYNES BARTON F
85 granted patents·84 pending applications·669 citations·filing 1987–2025
99Inventor score
Top patents by PatentIndex Score
169 records- 0196US7951377B2Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogensLOS ALAMOS NAT SECURITY LLC·Filed 2008·Granted May 31, 2011·37 cites·6 claims
- 0293US8048431B2Modified HIV-1 clade C envelope glycoprotein immunogens comprising deletions in the gp120/gp41 cleavage site and gp41 fusion domainUNIV DUKE·Filed 2007·Granted Nov 1, 2011·17 cites·1 claims
- 0392US10149902B2Swarm immunization with envelopes from CH505UNIV DUKE·Filed 2015·Granted Dec 11, 2018·7 cites·20 claims
- 0491US11421031B2Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereofMACROGENICS INC·Filed 2020·Granted Aug 23, 2022·2 cites·22 claims
- 0591US11136380B2Anti-complement factor H antibodiesUNIV DUKE·Filed 2018·Granted Oct 5, 2021·6 cites·14 claims
- 0690US6091000ASCID mouse engrafted with human synovium tissueUNIV DUKE·Filed 1992·Granted Jul 18, 2000·54 cites·4 claims
- 0789US8119140B2Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteinsKORBER BETTE T·Filed 2006·Granted Feb 21, 2012·12 cites·7 claims
- 0889US8071107B2Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteinsHAYNES BARTON F·Filed 2004·Granted Dec 6, 2011·26 cites·8 claims
- 0988US10865238B1Complement factor H antibodiesUNIV DUKE·Filed 2018·Granted Dec 15, 2020·5 cites·12 claims
- 1088US9963501B2B cell lineage based immunogen design with humanized animalsREGENERON PHARMA·Filed 2014·Granted May 8, 2018·6 cites·14 claims
- 1188US9011875B2Human immunodeficiency virus type 1 clade M mosaic gag polypeptidesKORBER BETTE T·Filed 2012·Granted Apr 21, 2015·5 cites·6 claims
- 1287US10183988B2Anti-Complement factor H antibodiesUNIV DUKE·Filed 2014·Granted Jan 22, 2019·7 cites·15 claims
- 1387US9011873B2Nucleic acids encoding mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogensKORBER BETTE T·Filed 2011·Granted Apr 21, 2015·4 cites·18 claims
- 1487US7195768B2Polyvalent immunogenUNIV CALIFORNIA·Filed 2003·Granted Mar 27, 2007·23 cites·9 claims
- 1587US7172761B2Polyvalent immunogenUNIV CALIFORNIA·Filed 2003·Granted Feb 6, 2007·18 cites·9 claims
- 1686US12286471B2Inhibitors of complement factor HUNIV DUKE·Filed 2024·Granted Apr 29, 2025·0 cites·6 claims
- 1786US11318197B2Compositions and methods for inducing HIV-1 antibodiesUNIV DUKE·Filed 2018·Granted May 3, 2022·5 cites·31 claims
- 1886US9044445B2Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogensKORBER BETTE T·Filed 2009·Granted Jun 2, 2015·4 cites·18 claims
- 1985US9492532B2Nucleic acids encoding mosaic HIV-1 gag proteinsUNIV DUKE·Filed 2015·Granted Nov 15, 2016·2 cites·18 claims
- 2085US7070787B2Method of inducing the production of antibodies to HIVUNIV DUKE·Filed 2003·Granted Jul 4, 2006·10 cites·18 claims
- 2185US7033593B2Immunogen comprising an HIV envelope protein, a ligand and H2 peptideUNIV DUKE·Filed 2003·Granted Apr 25, 2006·11 cites·28 claims
- 2284US10450368B2HIV-1 neutralizing antibodies and uses thereof (CD4bs antibodies)UNIV DUKE·Filed 2016·Granted Oct 22, 2019·5 cites·39 claims
- 2384US10076567B2MPER-liposome conjugates and uses thereofUNIV DUKE·Filed 2014·Granted Sep 18, 2018·3 cites·31 claims
- 2484US10004800B2Antibody evolution immunogensUNIV DUKE·Filed 2013·Granted Jun 26, 2018·6 cites·24 claims
- 2584US9908938B2Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereofMACROGENICS INC·Filed 2014·Granted Mar 6, 2018·6 cites·27 claims
- 2684US9402893B2Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodiesHAYNES BARTON F·Filed 2007·Granted Aug 2, 2016·5 cites·22 claims
- 2784US7101552B2Immunogen comprising an HIV envelope protein, a ligand and H2 peptideUNIV DUKE·Filed 2001·Granted Sep 5, 2006·9 cites·13 claims
- 2884US5013548AProduction of antibodies to HIVUNIV DUKE·Filed 1988·Granted May 7, 1991·75 cites·4 claims
- 2983US10717778B2Bispecific molecules comprising an HIV-1 envelope targeting armUNIV DUKE·Filed 2015·Granted Jul 21, 2020·3 cites·20 claims
- 3083US9855329B2Mosaic HIV envelope immunogenic polypeptidesLOS ALAMOS NAT SECURITY LLC·Filed 2014·Granted Jan 2, 2018·5 cites·13 claims
- 3183US5019387AProduction of antibodies to HIVUNIV DUKE·Filed 1987·Granted May 28, 1991·63 cites·15 claims
- 3282US12173051B2Bispecific molecules comprising an HIV-1 envelope targeting armUNIV DUKE·Filed 2020·Granted Dec 24, 2024·1 cites·16 claims
- 3382US9844590B2Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogensLOS ALAMOS NAT SECURITY LLC·Filed 2015·Granted Dec 19, 2017·2 cites·9 claims
- 3482US9821053B2Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteinsUNIV DUKE·Filed 2015·Granted Nov 21, 2017·2 cites·18 claims
- 3582US9717789B2Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodiesUNIV DUKE·Filed 2016·Granted Aug 1, 2017·2 cites·18 claims
- 3681US11161895B2Methods to identify immunogens by targeting improbable mutationsUNIV DUKE·Filed 2017·Granted Nov 2, 2021·2 cites·26 claims
- 3781US10968255B2Compositions comprising HIV envelopes to induce CH235 lineage antibodiesUNIV DUKE·Filed 2017·Granted Apr 6, 2021·2 cites·16 claims
- 3881US7998471B2Mycobacteria expressing HIV-1 and malaria antigensEINSTEIN COLL MED·Filed 2006·Granted Aug 16, 2011·5 cites·14 claims
- 3981US7153509B2Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitopeUNIV CALFORINIA·Filed 2002·Granted Dec 26, 2006·19 cites·16 claims
- 4080US2025282856A1Inhibitors of complement factor hUNIV DUKE·Filed 2025·Application pending·0 cites
- 4179US10730947B2Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereofMACROGENICS INC·Filed 2018·Granted Aug 4, 2020·1 cites·18 claims
- 4279US6544747B2Assay systemUNIV DUKE·Filed 2001·Granted Apr 8, 2003·7 cites·8 claims
- 4379US5993819ASynthetic vaccine for protection against human immunodeficiency virus infectionUNIV DUKE·Filed 1995·Granted Nov 30, 1999·37 cites·2 claims
- 4477US11071783B2HIV-1 neutralizing antibodies and uses thereofUNIV DUKE·Filed 2016·Granted Jul 27, 2021·2 cites·26 claims
- 4577US10626168B2B cell lineage based immunogen design with humanized animalsREGENERON PHARMA·Filed 2018·Granted Apr 21, 2020·1 cites·18 claims
- 4677US6982086B2Human immunodeficiency virus immunogenic compositionBETH ISRAEL HOSPITAL·Filed 2001·Granted Jan 3, 2006·7 cites·4 claims
- 4777US2023167178A1Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses ThereofMACROGENICS INC·Filed 2022·Application pending·0 cites
- 4876US9402917B2Methods for the induction of broadly anti-HIV-1 neutralizing antibody responses employing liposome-MPER peptide compositionsALAM S MUNIR·Filed 2010·Granted Aug 2, 2016·5 cites·28 claims
- 4976US8956627B2Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugatesHAYNES BARTON F·Filed 2008·Granted Feb 17, 2015·2 cites·19 claims
- 5076US2025042980A1Complement factor h antibodiesUNIV DUKE·Filed 2023·Application pending·0 cites
Showing the top 50 of 169 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Barton F. Haynes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →